Abstract
Beyond lymphedema, in its diverse manifestations, there is a spectrum of human disease that directly or indirectly alters lymphatic structure and function. Diagnosis and differential diagnosis pose distinct challenges. In this overview, various categories of lymphatic disease are enumerated and viewed through the prism of lymphatic embryological development.
-
Defects in the growth and development of lymphatic vessels underlie the lymphatic clinical disorders, including lymphedema, vascular malformations, and lymphangiectasia.
-
Lymphedema represents the most commonly encountered disease state of the lymphatics. It can present in both acquired and heritable forms.
-
Clinical manifestations of primary lymphedema can be mistaken for secondary lymphedema if edema first appears after an apparent provoking secondary inciting event.
-
A genetic predisposition for the development of lymphedema, even when the inciting secondary events are easy to identify.
-
There are at least nine causal mutations known for inherited human lymphedema.
-
Beyond peripheral lymphedema, the spectrum of lymphatic vascular disease is remarkably diverse. The pathological alterations can be isolated, regionalized, or diffuse and can occur in isolation or in concert with other complex vascular lesions.
-
Lymphatic malformations are microcystic, macrocystic, or mixed; generalized lymphatic anomaly is a multifocal lymphatic malformation that can involve the skin, superficial soft tissues, bone, and abdominal and thoracic viscera.
-
In protein-losing enteropathy, loss of lymphatic fluid and plasma protein within the lumen of the gastrointestinal tract can lead to edema and hypoproteinemia.
Highlighted References
Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest. 2014;124(3):915–21.
Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84(4):303–14.
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the International Society for the Study of vascular anomalies. Pediatrics. 2015;136(1):e203–14.
Radhakrishnan K, Rockson SG. The clinical spectrum of lymphatic disease. Ann N Y Acad Sci. 2008;1131:155–84.
References
Secker GA, Harvey NL. VEGFR signaling during lymphatic vascular development: from progenitor cells to functional vessels. Dev Dyn. 2015;244(3):323–31.
Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002;21(7):1505–13.
Kazenwadel J, Harvey NL. Morphogenesis of the lymphatic vasculature: a focus on new progenitors and cellular mechanisms important for constructing lymphatic vessels. Dev Dyn. 2016;245(3):209–19.
Rockson SG. Lymphedema. Am J Med. 2001;110(4):288–95.
Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008;52(10):799–806.
Nakamura K, Rockson SG. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol. 2008;6(3–4):181–9.
Greene AK, Grant FD, Maclellan RA. Obesity-induced lymphedema nonreversible following massive weight loss. Plast Reconstr Surg Glob Open. 2015;3(6):e426.
Greene AK, Grant FD, Slavin SA, Maclellan RA. Obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg. 2015;135(6):1715–9.
Rockson SG. The unique biology of lymphatic edema. Lymphat Res Biol. 2009;7(2):97–100.
Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One. 2013;8(4):e60164.
Nonne M. Vier Fälle von elephantiasis congenita hereditaria. Virchows Arch. 1891;125:189–96.
Milroy W. An undescribed variety of hereditary oedema. NY Med J. 1892;56:505–8.
Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42(2):98–102.
Falls HF, Kertesz ED. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans Am Ophthalmol Soc. 1964;62:248–75.
Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000;161(3 Pt 1):1037–46.
Connell FC, Kalidas K, Ostergaard P, Brice G, Murday V, Mortimer PS, et al. CCBE1 mutations can cause a mild, atypical form of generalized lymphatic dysplasia but are not a common cause of non-immune hydrops fetalis. Clin Genet. 2012;81(2):191–7.
Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085.
Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology. 2001;219(1):86–90.
Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics. 1990;86(6):988–94.
Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults. World J Gastrointest Oncol. 2011;3(2):19–23.
Fox U, Lucani G. Disorders of the intestinal mesenteric lymphatic system. Lymphology. 1993;26(2):61–6.
Jermann M, Eid K, Pfammatter T, Stahel R. Maffucci‘s syndrome. Circulation. 2001;104(14):1693.
Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H. Maffucci syndrome and neoplasms: a case report and review of the literature. BMC Res Notes. 2016;9:126.
Patel DV. Gorham's disease or massive osteolysis. Clin Med Res. 2005;3(2):65–74.
Ozeki M, Fujino A, Matsuoka K, Nosaka S, Kuroda T, Fukao T. Clinical features and prognosis of generalized lymphatic anomaly, kaposiform lymphangiomatosis, and gorham-stout disease. Pediatr Blood Cancer. 2016;63(5):832–8.
Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay syndrome: a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth. Int J Dermatol. 2006;45(8):883–90.
Revencu N, Boon LM, Dompmartin A, Rieu P, Busch WL, Dubois J, et al. Germline mutations in RASA1 are not found in patients with klippel-trenaunay syndrome or capillary malformation with limb overgrowth. Mol Syndromol. 2013;4(4):173–8.
Okhovat JP, Alavi A. Lipedema: a review of the literature. Int J Low Extrem Wounds. 2015;14(3):262–7.
Warren AG, Janz BA, Borud LJ, Slavin SA. Evaluation and management of the fat leg syndrome. Plast Reconstr Surg. 2007;119(1):9e–15e.
Glasgow CG, Taveira-DaSilva A, Pacheco-Rodriguez G, Steagall WK, Tsukada K, Cai X, et al. Involvement of lymphatics in lymphangioleiomyomatosis. Lymphat Res Biol. 2009;7(4):221–8.
Moir LM. Lymphangioleiomyomatosis: current understanding and potential treatments. Pharmacol Ther. 2016;158:114–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Rockson, S.G. (2018). Etiology and Classification of Lymphatic Disorders. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-52423-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52421-4
Online ISBN: 978-3-319-52423-8
eBook Packages: MedicineMedicine (R0)